Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy

BACKGROUND: Localized splenic histiocytic sarcoma (HS) in dogs is a poorly understood disease, and could have longer survival times than disseminated or hemophagocytic HS. Understanding the clinical behavior of localized splenic HS can refine treatment recommendations. OBJECTIVE: To describe the cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Latifi, Max, Tuohy, Joanne L., Coutermarsh‐Ott, Sheryl L., Klahn, Shawna L., Leeper, Haley, Dervisis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694829/
https://www.ncbi.nlm.nih.gov/pubmed/32986268
http://dx.doi.org/10.1111/jvim.15910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694829/
https://www.ncbi.nlm.nih.gov/pubmed/32986268
http://dx.doi.org/10.1111/jvim.15910

Ejemplares similares